Why are Cancer drugs so costly ? At present, India has an estimated 100,000 patients with breast cancers that can be treated with Herceptin and just five per cent of them can afford it. Herceptin was first marketed in India for Rs.1.2 lakh per vial and later at Rs.92,000 and finally Rs.75,000. In comparison, Biocon will sell the drug at around Rs.20,000. Certainly, it's much cheaper, but will it be affordable too? The cheaper version will make little or no difference.
Full article in the link below.
Read more at: http://indiatoday.intoday.in/story/breast-cancer-kiran-mazumdar-shaw-biocon-cancer-drug-trastuzumab/1/339021.html www.keralites.net
__._,_.___
KERALITES - A moderated eGroup exclusively for Keralites...
To subscribe send a mail to Keralites-subscribe@yahoogroups.com.
Send your posts to Keralites@yahoogroups.com.
Send your suggestions to Keralites-owner@yahoogroups.com.
To unsubscribe send a mail to Keralites-unsubscribe@yahoogroups.com.
Homepage: http://www.keralites.net
To subscribe send a mail to Keralites-subscribe@yahoogroups.com.
Send your posts to Keralites@yahoogroups.com.
Send your suggestions to Keralites-owner@yahoogroups.com.
To unsubscribe send a mail to Keralites-unsubscribe@yahoogroups.com.
Homepage: http://www.keralites.net
.
__,_._,___
No comments:
Post a Comment